ALSO NOTED: Pfizer transfers HG in Germany; NICE reversal on Alimta; Barr gets copycat OK; and much more...

> Pfizer is transferring its German HQ from Berlin to Karlsruhe. Report

> The UK's NICE has reversed itself, calling for the use of Eli Lilly's Alimta in fighting asbestos-related cancer. Report

> The FDA has approved Barr's copycat version of Dostinex. Report

> InterMune has struck a new supply agreement on Actimmune. Report

And Finally... Medicare and insurers are paying billions of dollars for new therapies to treat atrial fibrillation, even though most of the therapies are unproven. Report

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.